| Report ID | 275687 |
| Drug Identification Number | 02537117 |
| Brand name | LOCAMETZ |
| Common or Proper name | LOCAMETZ 25MCG |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALLIUM |
| Strength(s) | 25MCG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS |
| Packaging size | 25mcg |
| ATC code | V09IX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-01-09 |
| Actual start date | 2026-01-09 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-12 | French | Compare |
| v1 | 2026-01-12 | English | Compare |
Showing 1 to 2 of 2